“Pharma Bro” Shkreli’s Former Pharmaceutical Company Pays $40 Million To Settle Antitrust Suit

A bipartisan group of AGs, led by New York AG Letitia James, and the FTC reached a settlement with pharmaceutical company Vyera Pharmaceuticals (formerly known as Turing Pharmaceuticals) and its parent company (collectively “Vyera”) as well as one of its former CEOs, Kevin Mulleady, to resolve allegations that Vyera engaged in anticompetitive and monopolistic practices in violation of the FTC Act, the Sherman Act, and state antitrust laws.
The complaint alleged that Vyera, Mulleady, and another former CEO, […]

By | December 23rd, 2021 ||

Antitrust Scrutiny Heating Up In Oil And Gas Industries

President Biden recently wrote a letter to FTC Chair Lina Khan urging the Commission to immediately investigate potential anticompetitive behavior in the oil and gas sector. The President noted that gas prices have been rising, while the costs faced by oil and gas companies themselves have decreased. Concerned that the two largest oil and gas companies in the country are set to double their net income over 2019 while the gap between the price of unfinished […]

By | December 13th, 2021 ||

Uncharted Territory: Antitrust Enforcement In The Technology Sector

Morrison & Foerster is proud to sponsor the 2021 National Asian Pacific American Bar Association (NAPABA) Convention and Women’s Leadership Network. The Convention, taking place this week December 9-12, 2021, in Washington, D.C., brings together Asian American and Pacific Islander legal professionals from across the country and across all sectors and practices.

Bonnie Lau, partner in MoFo’s Global Antitrust Law Practice Group, will speak on a panel titled “Uncharted Territory: Antitrust Enforcement in the Technology […]

By | December 3rd, 2021 ||